Article
Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.
The American journal of tropical medicine and hygiene - 1 Jan 2015
Gromowski Gregory D, Firestone Cai-Yen, Bustos-Arriaga José, Whitehead Stephen S
Abstract excerpt
The live-attenuated Japanese encephalitis virus (JEV) SA14-14-2 vaccine, produced in primary hamster kidney cells, is safe and effective. Past attempts to adapt this virus to replicate in cells that are more favorable for vaccine production resulted in mutations that significantly reduced immunogenicity. In this study, 10 genetically distinct Vero cell-adapted JEV SA14-14-2 variants were isolated and a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
